HUMHumana

$431.00+65% 1Y

Is it safe?

Mixed

Forensics clean, with a caveat: a safe balance sheet and comfortable debt (AA), but big price swings.

2 good, 1 to watch, 3 without data
SurvivalSafe zoneSEC EDGAR · Dec 31, 2025

Financially healthy, low distress risk Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Credit gradeAAderived · Mar 31, 2026

Net cash and profitable. A rule of thumb on leverage, not a credit rating.

Drawdown risk48% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -70% · now 3% below its 52-week high.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitymiddle of the market
Max drawdownmiddle of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can HUM take a bad year?

Humana holds $7.97B more cash than debt, so a bad year is a question about profits, not about lenders.

$7.97B

Net cash

Net debt / EBITDA
net cash

Net debt / EBITDA · no net borrowings to measure against earnings

Altman Z-score
4.91

Altman Z-score · safe zone, above 3

Interest cover
3.68×

Interest cover · operating profit covers the interest bill, with room to spare

Details›
Total debtQ1 2026
$14.0B
Cash and short-term investments
$22.0B
Net cash
$7.97B
EBITDA, trailing twelve months
$3.12B
Operating profit, trailing twelve months
$2.44B
Debt / equity
0.75×
Total debt / EBITDA
4.48×
Annualised volatilitytwo years of daily moves
48%
Worst drawdown on file
−70%
Below its 52-week high
2.8%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.